Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Salles
    Salles
  9. Horwitz
    Horwitz
  10. Perales
    Perales

Groups

  1. Department of Medicine (296)
  2. Hematologic Malignancies, Division of (295)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (44)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (124)
  3. Research Letter (26)
  4. Editorial (17)
  5. Review (12)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (296)
  2. Hematologic Malignancies, Division of (295)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (19)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (355)
  2. Haematologica Meeting Reports (4)

Results (359)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CDKN2A deletion is a frequent event associated with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS)
    Journal Article

    Maura, F.; Dodero, A.; Carniti, C.; Bolli, N.; Magni, M.; Monti, V.; Cabras, A.; Leongamornlert, D.; Abascal, F.; Diamond, B.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia
    Journal Article

    Geyer, M. B.; Ritchie, E. K.; Rao, A. V.; Vemuri, S.; Flynn, J.; Hsu, M.; Devlin, S. M.; Roshal, M.; Gao, Q.; Shukla, M.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Aumento del uso y del coste de recursos sanitarios en pacientes hospitalizados seropositivos para CMV receptores de trasplantes alogénicos de células madre hematopoyéticas bajo tratamiento preventivo
    Meeting Abstract

    Fernandez-Cuesta, I.; Fang, J.; Zavras, P. D.; Su, Y.; Raval, A.; Tang, Y.; Stern, A.; Perales, M. A.; Giralt, S.; Papanicolaou, G.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Somatic mutations are shared between circulating endothelial cells (CEC) and CD34+ hematopoietic stem cells (HSC) in patients with primary myelofibrosis. Can PMF-initiating cells derive from a common HSC/EC precursor?
    Meeting Abstract

    Farina, M.; Bernardi, S.; Polverelli, N.; Zanaglio, C.; D'Adda, M.; Malagola, M.; Re, F.; Cattina, F.; Zollner, T.; Rossi, G.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • Revealing transcriptome deregulation upon genomic complexity in multiple myeloma
    Meeting Abstract

    Ziccheddu, B.; Da Vià, M. C.; Dugo, M.; Lionetti, M.; Todoerti, K.; D'Agostino, M.; Neri, A.; Maura, F.; Corradini, P.; Bolli, N.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Modulation of the immune microenviroment in multiple myeloma patients treated with daratumumab-based therapy: Tumor cell-extrinsic effects of daratumumab treatment
    Meeting Abstract

    Castella, B.; D'Agostino, M.; Giannotta, C.; Oliva, S.; Genuardi, E.; Gilestro, M.; Ruggeri, M.; Corradini, P.; Ziccheddu, B.; Maura, F.; more...
    Haematologica (2020)

    Fulltext@MSK | Save
  • New option for improving hematological recovery: Suppression of luteinizing hormone
    Editorial

    Elias, H. K.; Van den Brink, M. R. M.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Peripheral neuropathy and monoclonal gammopathy of undetermined significance: A population-based study including 15,351 cases and 58,619 matched controls
    Correspondence

    Rognvaldsson, S.; Steingrimsson, V.; Turesson, I.; Bjorkholm, M.; Landgren, O.; Kristinsson, S. Y.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: A systematic review and meta-analysis
    Research Letter

    Bewersdorf, J. P.; Giri, S.; Wang, R.; Williams, R. T.; Tallman, M. S.; Zeidan, A. M.; Stahl, M.
    Haematologica (2020)

    Fulltext@MSK | Save
  • Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial
    Research Letter

    Ghia, P.; Coutre, S. E.; Cheson, B. D.; Barrientos, J. C.; Hillmen, P.; Pettitt, A. R.; Zelenetz, A. D.; Shreay, S.; Hallek, M.; Furman, R. R.
    Haematologica (2020)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: